BACKGROUND AND AIM

The global incidence of melanoma is rising steadily. Despite significant advancements in therapeutic options, resistance mechanisms often emerge, leading to disease progression. This event underscores the importance of identifying novel intracellular targets. The transient receptor potential melastatin subtype 8 (TRPM8), a non-selective cation channel with a preference for calcium permeation, is aberrantly expressed in various solid malignancies, including melanoma. Thus, it could represent a promising therapeutic target in melanoma cells.

METHODS

Two melanoma cell lines, derived from subcutaneous and lymph node metastases, were utilized to investigate the effects of TRPM8 modulators. Multiple methodologies, including colorimetric assays, Western blotting, immunofluorescence (IF), and confocal microscopy, were employed to assess the biological impact of these modulators.

RESULTS

Time-course experiments demonstrated that TRPM8 modulators induced melanoma cell death. These findings were corroborated by dual-fluorescence IF analyses. Further investigation of the molecular mechanisms revealed that the apoptotic pathway triggered by these modulators involved caspase 3 activation.

CONCLUSIONS

Additional studies are necessary to elucidate the regulatory mechanisms of TRPM8 and the resulting calcium influx dynamics. Nonetheless, the identification of novel chemotherapeutic targets with enhanced potency and selectivity may pave the way for innovative melanoma treatment strategies. These approaches hold significant promise for advancing oncology therapeutics.